SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu ($SAILANA) is experiencing significant community buzz, propelled by the recent launch and adoption of its cross-chain WolfSWAP aggregator. The dedicated 'Wolfpack' community is highly bullish, emphasizing Sailana's utility-driven approach, decentralized governance through WolfDAO, and an anticipated groundbreaking flagship product. Many are comparing its current trajectory to the early days of Shiba Inu, highlighting its potential as a strong, community-focused project in the crypto space.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corporation (OMER) is seeing intense trading activity after receiving FDA approval for YARTEMLEA, its groundbreaking, first-in-class treatment for transplant-associated thrombotic microangiopathy (TA-TMA) in both adults and children. This landmark approval, validating their MASP-2 platform and offering a de-risked revenue stream, has fueled widespread bullish sentiment and discussions around a potential short squeeze or even a buyout, bolstered by their existing $2.1 billion partnership with Novo Nordisk. The community is actively discussing the company's significantly enhanced value and future prospects ahead of their upcoming conference call.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is a major talking point following the FCC's recent action to ban foreign-manufactured drones, which is expected to significantly benefit domestic producers. Community sentiment is mixed, with strong bullish anticipation for upcoming government contracts, increased production capabilities, and its unique position within the defense sector, while some investors express frustration over delays in contract announcements and past guidance. The broader context of escalating defense spending on unmanned systems, including USVs and small UAS, fuels expectations for substantial revenue growth.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to robust earnings, strong guidance, and its pivotal role in the booming AI sector, particularly with its High-Bandwidth Memory (HBM) products. The market is excited about escalating demand for AI semiconductors, with reports of big tech firms scrambling to secure memory supply and HBM prices rising significantly. Community sentiment is overwhelmingly bullish, touting Micron as the "NVDA of Memory" and emphasizing its current undervaluation and substantial growth potential amidst a structural shift in memory demand.

CD Projekt SA is a holding company, which engages in the development of video games. It operates through the CD PROJEKT RED and GOG.com segments. The CD PROJEKT RED segment focuses on videogame development. The GOG.com segment distributes global digital videogame. Its other activities include motion picture distribution and investment services. The company was founded by Marcin Piotr Iwinski in 1994 and is headquartered in Warsaw, Poland.

CD Projekt S.A. - ADR

CD Projekt 4 ADR Representing Ord Shs

CD Projekt is actively trending as it pushes forward with its highly anticipated game pipeline, including The Witcher 4 now in full-scale production and Cyberpunk 2 advancing with growing development teams. This momentum, supported by strong financial performance and continued sales from its acclaimed titles, drives considerable community discussion and investor interest in the future of its narrative-driven franchises.

Taseko Mines Ltd. operates as a mining company which engages in the acquisition, development, and operation of mineral deposits. It holds interest in the Gibraltar, Florence Copper, Aley Niobium, Yellowhead, New Prosperity, and Harmony projects. The company was founded on April 15, 1966 and is headquartered in Vancouver, Canada.

Taseko Mines Ltd.

Taseko Mines is generating significant buzz due to escalating copper prices and the eagerly anticipated production start of its Florence Copper project in Arizona. The community is highly focused on this low-cost, environmentally friendly U.S. mine, expecting it to transform the company's output and capitalize on domestic demand, further amplified by recent tariff discussions. This pivotal moment, coupled with progress on other projects, fuels strong bullish sentiment for TGB's future in a tight copper market.

Bitwise 10 Crypto Index ETF - Common Shares Of Beneficial Interest

Bitwise 10 Crypto Index Fund

Bitwise 10 Crypto Index Fund (BITW OTC) is trending amid intense debate over the crypto market's future, with a vocal bearish faction predicting a severe "crypto winter" and a significant Bitcoin price crash based on historical cycles. Countering this, other investors highlight growing institutional adoption, the potential for ETF approvals, and BITW's current discount to Net Asset Value (NAV) as it seeks to convert to an ETP, suggesting a different outlook for the diversified crypto fund.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus is drawing significant attention following its selection for the U.S. Space Force SHIELD contract vehicle, an event the community is calling "Golden Dome" news. This development, combined with its role as a SpaceX partner for an upcoming mission and an exceptionally low share count post-reverse split, has positioned it as a high-interest play within the actively discussed aerospace sector. Investors are weighing its contract wins and tight share structure against past concerns about dilution, fueling a speculative outlook.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending following its recent earnings report, which showcased revenue growth and narrowing losses, coupled with a strong strategic focus on providing "always-on" power solutions for the expanding AI data center market. The community is actively discussing whether this renewed direction, supported by recent financing, will translate into substantial contracts and sustained profitability, drawing both bullish comparisons to sector peers and skeptical concerns over past dilution and the absence of concrete deals. This discussion is set against the backdrop of the broader fuel cell industry's efforts to meet the escalating energy demands of artificial intelligence infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Issues CRL to SNY's Regulatory Filing for Multiple Sclerosis Drug

Sanofi receives an FDA CRL for tolebrutinib in nrSPMS after multiple review extensions. The EC clears Wayrilz for treating immune thrombocytopenia.

AGIO's Mitapivat Gets FDA Nod for Thalassemia Indication with REMS in Label

Agios Pharmaceuticals wins FDA approval for Aqvesme in alpha- and beta-thalassemia, making mitapivat the only approved option, despite a new REMS.

Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise

SNY's $2.2 billion deal for Dynavax adds Heplisav-B, a shingles candidate, and other vaccine programs, strengthening its adult vaccine franchise and pipeline.

What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing'

Castle Biosciences (CSTL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead exercises its option to license ASMB's HSV programs for developing long-acting candidates, ABI-1179 & ABI-5366, for recurrent genital herpes.

CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies

CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.

JNJ's Tremfya Gets EU Approval for Pediatric Plaque Psoriasis

Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.

AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Revised)

AstraZeneca's Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.

AZN, Daiichi's Enhertu Gets Breakthrough Tag for Expanded Cancer Use

AstraZeneca's Enhertu wins FDA Breakthrough tag for expanded use in breast cancer, while a late-stage study on ceralasertib + Imfinzi in lung cancer misses its goal.

Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month High After Analyst Upgrade

Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year High After Analyst Upgrade...

Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.

CSTL
Castle Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CSTL News

CSTLCastle Biosciences Inc